Larimar Therapeutics, Inc. LRMR 深 滬
已收盤 02-06 16:00:00 美东时间
3.37
+0.300
+9.77%
華盛通- 最 高3.405
- 今 開3.13
- 成交量 109.16万股
- 最 低 3.11
- 昨 收 3.07
- 總市值 2.80亿
- 52周最高 5.37
- 市盈率 靜 --
- 換手率 1.31%
- 52周最低 1.61
- 委 比 -35.92%
- 總股本 8309.04万
- 歷史最高 664.32
- 量 比 1.02
- 振 幅 9.61%
- 歷史最低 1.53
- 每 手 1
- 風險率 0.75%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Larimar Therapeutics executes preferred stock exchange and amendment
Larimar Therapeutics ( ($LRMR) ) has provided an update. On January 21, 2026, L...
01-22 20:29
Larimar Therapeutics Announces Exchange of Common Shares for Series A Convertible Preferred Stock
Larimar Therapeutics Announces Exchange of Common Shares for Series A Convertible Preferred Stock Larimar Therapeutics Inc. has announced an unregistered sale of equity securities through an exchange agreement with Blue Owl Healthcare Opportunities IV Public Investments LP. Under the agreement, Blue
01-22 20:02
Larimar advances nomlabofusp toward accelerated Friedreich’s ataxia approval
An update from Larimar Therapeutics ( ($LRMR) ) is now available. On January 12...
01-13 05:50
Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
<p>Larimar Therapeutics will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco from January 12–15, 2026. Its management team will present and hold 1x1 investor meetings, including a presentation on January 14, 2026, at 9:00–9:40 AM PST. A webcast link and replay will be available post-presentation. Larimar focuses on developing treatments for complex rare diseases, with its lead compound targeting Friedreich's atax...
2025-12-18 13:00
Larimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment
Larimar Therapeutics, Inc. ( ($LRMR) ) has released its Q3 earnings. Here is a ...
2025-11-07 14:53
Larimar Therapeutics Q3 EPS $(0.61) Misses $(0.40) Estimate
Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.40) by 51.36 percent. This is a 154.17 percent decrease over losses of $(0.24) per
2025-11-05 20:09
Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining aroun...
2025-10-06 20:09
美股大行评级 | 潜在涨幅216.96%！Kazia Therapeutics获Maxim Group升目标价至20美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持Kazia Therapeutics"买入"评级，目标价从15美元升至20美元；Baird：维持Taysha Gene Therapies"跑赢大市"评级，目标价从7美元升至12美元
2025-10-03 14:32
美股牛股 | AI基础设施REIT公司Fermi上市首日收涨54.9%；DXYZ大涨超30%
AI基础设施REIT公司Fermi登陆美股首日收涨54.9%，市值近200亿美元；DXYZ大涨超30%
2025-10-02 16:55
美股大行评级 | 潜在涨幅超31%！摩根大通维持通用汽车"超配"评级，目标价从60美元升至80美元
今日重点评级关注：Maxim Group：上调Adial Pharmaceuticals评级至"买入"，目标价1.5美元；BTIG：维持Climb Bio"买入"评级，目标价从7美元升至8美元
2025-10-01 20:13
